RxDoctor Payments Data

Jonathan Shum, MD

Oral & Maxillofacial Surgery · Houston, TXNPI 1518110329

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,002 of the $10,342 with a category attached, or 77.4%. It is spread thinly across 16 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations. Among oral & maxillofacial surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,342in general payments, 2019–2025

Across 137 payments — averaging $75.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$2K
  • Kls-martin L.p.$2K
  • Axogen$2K
  • Johnson & Johnson$1K
  • Stryker$831
  • Acera Surgical, Inc.$625
  • plus $958 from 10 others

What the payments were for

  • Consulting fees$2,34023%
  • Food & beverage$8,00277%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,342 in reported general payments places this provider in the 90th percentile of 591 oral & maxillofacial surgery providers in Texas.

See all oral & maxillofacial surgery providers in Texas

Medicare billing

Part B allowed, 2024
$36,781
Medicare patients
73
Services billed
176

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav30$394
Doxycycline Hyclate15$273
Chlorhexidine Gluconate43$137

Paid to pharmacies, not to this prescriber.

Other oral & maxillofacial surgery in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →